Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,027 public trials 1,169 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, Not Recruiting

Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

NCT02811861

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Stanford School of Medicine Stanford, California, United States
  • Boca Raton Community Hospital Boca Raton, Florida, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • University of Miami Miami, Florida, United States
View all 183 locations
View Trial Details
Active, Not Recruiting

ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss

NCT04065269

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +26 more
Locations
  • The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • University of Montreal Hospital Centre Montreal, Quebec, Canada
  • Royal United Hospital Bath, United Kingdom
View Trial Details
Active, Not Recruiting

Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma

NCT04919122

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • State University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Ochsner Clinic Foundation d/b/a Ochsner Health New Orleans, Louisiana, United States
  • The Johns Hopkins University Baltimore, Maryland, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +46 more
Locations
  • Arizona Cancer Center at the Unvieristy of Arizona Tucson, Arizona, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Monument Health Cancer Care Institute Rapid City, South Dakota, United States
View Trial Details
Active, Not Recruiting

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

NCT05479812

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +37 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

NCT05239143

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Registry on Percutaneous Electrochemotherapy

NCT05267080

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • Centre Hospitalier Universitaire de Montpellier Montpellier, France
  • Hôpital Européen Georges-Pompidou Paris, France
  • Institut Gustave Roussy Paris, France
  • WEGE Klinik Bonn, Germany
View all 15 locations
View Trial Details

Related conditions